Celyad - Company & Market Research Reports

Celyad SA, a clinical-stage biopharmaceutical company, focuses on engineered cell therapy treatments. It develops therapeutic therapies for the treatment of unmet medical needs in cardiology and oncology. The company's best known product is the C-Cure, an autologous cell therapy for the treatment of heart failure. The company was formerly known as Cardio3 BioSciences SA and changed its name to Celyad SA in May 2015. Celyad SA was founded in 2004 and is based in Mont-Saint-Guibert, Belgium.

Report package: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-cells - Product Thumbnail Image

Report package: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-cells

  • Report
  • 618 Pages
From
Global CAR T Cell Therapy Market & Clinical Trials Insight 2022 - Product Thumbnail Image

Global CAR T Cell Therapy Market & Clinical Trials Insight 2022

  • Drug Pipelines
  • 240 Pages
From
CAR T-cell Therapy for Multiple Myeloma – A Pipeline Analysis Report - Product Thumbnail Image

CAR T-cell Therapy for Multiple Myeloma – A Pipeline Analysis Report

  • Report
  • 70 Pages
From
Bladder and Ureter Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
Current Research & Developments Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy - Product Thumbnail Image

Current Research & Developments Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy

  • Report
  • 273 Pages
From
Global CAR-T Cell Therapy Market - Market Size, Forecasts, Trials & Trends - Product Thumbnail Image

Global CAR-T Cell Therapy Market - Market Size, Forecasts, Trials & Trends

  • Report
  • 194 Pages
From
Strategic Development of Neural Stem & Progenitor Cell Products (2018) - Product Thumbnail Image

Strategic Development of Neural Stem & Progenitor Cell Products (2018)

  • Report
  • 210 Pages
From
Mesenchymal Stem Cells - Advances & Applications 2018 - Product Thumbnail Image

Mesenchymal Stem Cells - Advances & Applications 2018

  • Report
  • 216 Pages
From
The Global Market for Stem Cells - Product Thumbnail Image

The Global Market for Stem Cells

  • Report
  • 162 Pages
From
T-cell Immunotherapy: Clinical Trial Tracker - Product Thumbnail Image

T-cell Immunotherapy: Clinical Trial Tracker

  • Clinical Trials
From
Colorectal Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Colorectal Cancer Drug Development Pipeline Review, 2017

  • Report
  • 299 Pages
From
2018 Chronic Heart Failure Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Chronic Heart Failure Market - Product Thumbnail Image

2018 Chronic Heart Failure Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Chronic Heart Failure Market

  • Report
  • 70 Pages
From
T-Cell Immunotherapy Market (2nd Edition), 2017-2030 - Product Thumbnail Image

T-Cell Immunotherapy Market (2nd Edition), 2017-2030

  • Report
  • 654 Pages
From
T-Cell Immunotherapy Market (3rd Edition), 2018-2030 - Product Thumbnail Image

T-Cell Immunotherapy Market (3rd Edition), 2018-2030

  • Report
  • 850 Pages
From
Global Stem Cell Therapy Market Future Outlook - Product Thumbnail Image

Global Stem Cell Therapy Market Future Outlook

  • Report
  • 300 Pages
From
Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018

  • Report
  • 385 Pages
From
Myelodysplastic Syndrome - Pipeline Review, H1 2018 - Product Thumbnail Image

Myelodysplastic Syndrome - Pipeline Review, H1 2018

  • Drug Pipelines
  • 1006 Pages
From
CAR-T Therapies Market, 2018-2030 - Product Thumbnail Image

CAR-T Therapies Market, 2018-2030

  • Report
  • 548 Pages
From
Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 115 Pages
From
Drug analysis: C-Cure - Product Thumbnail Image

Drug analysis: C-Cure

  • Drug Pipelines
  • 15 Pages
From
Loading Indicator
adroll